Commonwealth Equity Services’s Vivos Therapeutics VVOS Stock Holding History

Commonwealth Equity Services’s Portfolio VVOS Stock Details VVOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.3K	Hold	42,500	–	–	﹤0.01%	4360
2026 Q1	$50.1K	Buy	42,500 +2,000	+5%	+$3.21K	﹤0.01%	4201
2025 Q4	$82.2K	Sell	40,500 -500	-1%	-$1.24K	﹤0.01%	4134
2025 Q3	$127K	Hold	41,000	–	–	﹤0.01%	4046
2025 Q2	$130K	Buy	41,000 +7,000	+21%	+$17.7K	﹤0.01%	4018
2025 Q1	$97K	Buy	34,000 +8,000	+31%	+$31.4K	﹤0.01%	3996
2024 Q4	$112K	Buy	26,000 +5,000	+24%	+$16.7K	﹤0.01%	3885
2024 Q3	$55K	Buy	21,000 +5,000	+31%	+$13.1K	﹤0.01%	3925
2024 Q2	$36K	Buy	16,000 +1,000	+7%	+$2.44K	﹤0.01%	3922
2024 Q1	$72K	Buy	+15,000	New	+$89.6K	﹤0.01%	3844

Other funds holding VVOS

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IWM

IHT Wealth Management Chicago, Illinois $4.7B AUM 25.67% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BRWA

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

CWM

Centurion Wealth Management Mclean, Virginia $418M AUM 23.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Commonwealth Equity Services's VVOS Position: Q2 2026 in Review

Commonwealth Equity Services held its Vivos Therapeutics (VVOS) position steady in Q2 2026 at 42,500 shares worth $19.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4360.

Commonwealth Equity Services first reported a position in VVOS in Q1 2024 and has held it in 10 quarters since. The position peaked at $130K in Q2 2025. 23 funds tracked by Wall St. Rank hold VVOS as of Q2 2026.

Commonwealth Equity Services held 42,500 shares of Vivos Therapeutics worth $19.3K as of Q2 2026.
Commonwealth Equity Services left its Vivos Therapeutics share count unchanged in Q2 2026.
Vivos Therapeutics made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #4360 holding.
Commonwealth Equity Services first reported a position in Vivos Therapeutics in Q1 2024 and has held it in 10 quarters since.
Commonwealth Equity Services's Vivos Therapeutics position peaked at $130K in Q2 2025.
23 funds tracked by Wall St. Rank held Vivos Therapeutics as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.